The software provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyse and explore large volumes of multi-omic data in a secure, scalable and flexible environment.
Researchers have developed a fully automated, low-cost and rapid microrobotic diagnostic system with comparable sensitivity to clinical detection methods.
UK researchers have built an intelligent mobile robot scientist with the ability to work almost 24 hours a day and to carry out experiments by itself.
Molecular Devices' QPix 400 Series Microbial Colony Pickers are designed to fully automate synthetic biology workflows for DNA assembly, antibody discovery and protein engineering.
A Dublin-based tech start-up has announced the launch of Wirano — a digital platform for the rapid and effective organisation of clinical trials.
Researchers have devised a computational biology algorithm that can predict what molecules are needed to keep cells healthy in laboratory cultures.
A new mobile app has made it possible to analyse the genome of the SARS-CoV-2 virus on a smartphone in less than half an hour.
Biobanking or the storage of biospecimens is becoming increasingly more important in the area of biomedical research.
TTP Labtech has announced the chameleon sample preparation system for cryo-electron microscopy (cryo-EM), designed to enable consistent application of samples to high-quality foil grids for cryo-EM analysis.
Technology company ABB will introduce its collaborative robots to medical laboratories as it opens a new healthcare hub at the Texas Medical Center in Houston, Texas.
The protein purifier of today has a full agenda and many different tasks to perform. It can be difficult to find time for attending full runs in the lab.
Biotage's Extrahera is a powerful, user-friendly automation system for analytical sample preparation in plate or column formats. It is a compact, eight-channel automation instrument, designed for speed and flexibility and with end-user operation in mind.
Epileptic seizure prediction is now possible in a wider range of patients than previously thought, thanks to the crowdsourcing of more than 10,000 algorithms worldwide.
Queensland researchers have conducted a world-first trial comparing the merits of robotic-assisted prostatectomy to open prostatectomy.
'Ivy' is a self-improving artificial intelligence system that continuously learns from the embryos it analyses.